Standard Biotools Inc.LAB
Price (close)
$0.74
Market cap
$291.7M
P/E
3.4x
Revenue (TTM)
$84.6M
Net income
$84.9M
Dividend yield
—
1-year total return
-42.4%
Net margin
100.4%
Revenue growth
-4.8%
Debt / equity
—
What Standard Biotools Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $138.1M | $130.6M | $97.9M | $106.3M | $91.0M | $85.3M |
| Net income | -$53.0M | -$59.2M | -$190.1M | -$74.7M | -$138.9M | -$74.9M |
| Free cash flow | -$28.1M | -$57.3M | -$93.2M | -$46.1M | -$151.8M | -$82.6M |
More on LAB.
- Standard Biotools Inc. summary
- Standard Biotools Inc. financial statements
- Standard Biotools Inc. key metrics
- Standard Biotools Inc. health scores and style box
- Standard Biotools Inc. earnings
- Standard Biotools Inc. dividends
- Standard Biotools Inc. valuation
- Standard Biotools Inc. ownership and insiders
- Standard Biotools Inc. peers
Figures from Standard Biotools Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.